拜卡莱因通过调节大鼠DNMT1/GABRD途径来缓解-皮洛卡尔宾诱导的状态
Zhenggang Wu1, Jing Liu2, Deju Yin1
1Department of Neurology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.
Organogenesis
|June 26, 2025
概括
拜卡莱因抑制了GABRD基因的DNA甲基化,改善了老鼠的和认知功能. 这种表观遗传方法针对新的治疗方法的DNMT1/GABRD途径.
科学领域:
- 神经科学是一个神经科学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 病原发生涉及表观遗传变化,特别是影响GABAergic信号的DNA甲基化.
- 拜卡莱因具有抗和神经保护性质,但其在GABA受体调节中的表观遗传作用尚不清楚.
研究的目的:
- 在病模型中研究贝卡莱因对GABA受体功能的表观遗传效应.
- 探索DNMT1/GABRD轴在和贝卡莱因干预中的作用.
主要方法:
- 使用了一种化-皮洛卡尔宾诱导的状态 (SE) 鼠模型.
- 评估了认知功能,神经元损伤和炎症标志物.
- 染色体免疫沉和西部涂抹确定了DNMT1介导的GABRD促进物甲基化.
主要成果:
- 拜卡莱因延迟了SE发作,改善了发育,并改善了认知障碍.
- 拜卡莱因增加了神经元的存活率,并减少了海马中的神经炎症.
- 拜卡莱因抑制了DNMT1介导的GABRD促进物甲基化,增加了GABRD蛋白水平.
结论:
- DNMT1/GABRD轴是干预的新型表观遗传标.
- 拜卡莱因通过GABRD脱甲基化增强强力抑制,为耐药性提供了一种策略.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
671
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
671
Antiepileptic Drugs: Potassium Channel Activators
286
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
286
Mania and Antimanic Drugs: Overview
325
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
325
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
459
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
459
Antiepileptic Drugs: Glutamate Antagonists
526
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
526
Antiepileptic Drugs: Sodium Channel Blockers
927
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
927


